FDA authorizes first standalone robotic device to draw blood
· Medical Xpressby Lori Solomon
edited by Sadie Harley, reviewed by Andrew Zinin
Sadie Harley
Scientific Editor
Meet our editorial team
Behind our editorial process
Andrew Zinin
Chief Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
reputable news agency
proofread
The GIST Add as preferred source
The U.S. Food and Drug Administration has authorized Aletta as the first standalone robotic device that can draw blood from a patient's arm. Marketing authorization was granted to Vitestro.
The device is authorized for use in adult outpatients with the oversight of a trained phlebotomist. One phlebotomist can oversee up to three Aletta devices simultaneously, initiating each session and responding to any issues, while Aletta autonomously handles each step of the blood draw.
The device uses near-infrared light and Doppler ultrasound to locate a suitable vein and then proceeds through the remaining steps on its own: applying a tourniquet, preparing the skin, inserting and disposing of the needle, changing collection tubes and applying a bandage. Afterward, the supervising phlebotomist confirms that collection tubes are filled in the correct order and verifies that all tubes are adequately full.
The authorization is based on clinical data showing that the Aletta device achieves successful blood-draw rates comparable to or better than those of trained human phlebotomists. Trials included a broad range of patients across varying health statuses, including those who self-reported having difficult vein access and those with varying skin tones. Device-related adverse events were uncommon and mild.
"This authorization reflects the FDA's commitment to advancing innovative medical devices that help meet a critical public health need while maintaining the safety and effectiveness patients deserve," Michelle Tarver, M.D., Ph.D., from the FDA Center for Devices and Radiological Health, said in a statement.
"Blood draws are one of the most commonly performed medical procedures in the United States, yet patients may face delays due to a growing shortage of trained phlebotomists."
More information
FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Device
Key medical concepts
Clinical categories
Allied healthLaboratory medicine Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Copyright © 2026 HealthDay. All rights reserved.
Citation: FDA authorizes first standalone robotic device to draw blood (2026, August 21) retrieved 23 August 2026 from https://medicalxpress.com/news/2026-08-fda-authorizes-standalone-robotic-device.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.